These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19571709)

  • 21. Predominance of CIN versus MSI in the development of rectal cancer at young age.
    Fernebro E; Halvarsson B; Baldetorp B; Nilbert M
    BMC Cancer; 2002 Oct; 2():25. PubMed ID: 12379157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
    Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
    Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
    Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative evaluation of CpG island methylation in hyperplastic polyps.
    Vaughn CP; Wilson AR; Samowitz WS
    Mod Pathol; 2010 Jan; 23(1):151-6. PubMed ID: 19855373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
    van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
    BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of genetic disorders of cancer of the rectum: differences in relation to cancer of the colon].
    Rebischung C; Laurent-Puig P; Gerard JP; Thomas G; Hamelin R
    Gastroenterol Clin Biol; 1998; 22(8-9):679-87. PubMed ID: 9823556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation predicts recurrence from resected stage III proximal colon cancer.
    Ahn JB; Chung WB; Maeda O; Shin SJ; Kim HS; Chung HC; Kim NK; Issa JP
    Cancer; 2011 May; 117(9):1847-54. PubMed ID: 21509761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries.
    Chan AO; Soliman AS; Zhang Q; Rashid A; Bedeir A; Houlihan PS; Mokhtar N; Al-Masri N; Ozbek U; Yaghan R; Kandilci A; Omar S; Kapran Y; Dizdaroglu F; Bondy ML; Amos CI; Issa JP; Levin B; Hamilton SR
    Clin Cancer Res; 2005 Dec; 11(23):8281-7. PubMed ID: 16322286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer.
    Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF
    Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
    Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
    Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.
    Mima K; Nowak JA; Qian ZR; Cao Y; Song M; Masugi Y; Shi Y; da Silva A; Gu M; Li W; Hamada T; Zhang X; Wu K; Meyerhardt JA; Baba H; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
    Oncotarget; 2016 Aug; 7(34):55098-55109. PubMed ID: 27391152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
    Bae JM; Cho NY; Kim TY; Kang GH
    Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite alterations and K-ras, TGFbetaRII, IGFRII and bax mutations in sporadic cancers of the gastrointestinal tract.
    Caligo MA; Ghimenti C; Sensi E; Marchetti A; Bertacca G; Giulianotti PG; Fornaciari G; Bevilacqua G
    Oncol Rep; 2000; 7(6):1371-5. PubMed ID: 11032947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APC mutations and other genetic and epigenetic changes in colon cancer.
    Samowitz WS; Slattery ML; Sweeney C; Herrick J; Wolff RK; Albertsen H
    Mol Cancer Res; 2007 Feb; 5(2):165-70. PubMed ID: 17293392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
    APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
    Laskar RS; Ghosh SK; Talukdar FR
    Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
    Samowitz WS; Albertsen H; Sweeney C; Herrick J; Caan BJ; Anderson KE; Wolff RK; Slattery ML
    J Natl Cancer Inst; 2006 Dec; 98(23):1731-8. PubMed ID: 17148775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
    Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
    Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.